Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

4.08
Delayed Data
As of Oct 20
 -0.05 / -1.21%
Today’s Change
1.97
Today|||52-Week Range
5.78
+88.99%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close4.13
Today’s open4.08
Day’s range3.99 - 4.15
Volume108,722
Average volume (3 months)270,684
Market cap$184.0M
Dividend yield--
Data as of 4:00pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+55.10%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+28.97%
P/E ratioNM
Price/Sales2.77
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.30-6.67%
MDWDMediwound Ltd-0.10-1.96%
SRNESorrento Therapeutic...+0.30+12.00%
TRVNTrevena Inc+0.10+6.02%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateDecember 12, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$57.6M
Annual profit (last year)-$28.2M
Net profit margin-48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts